{"id":"https://openalex.org/W1973123797","doi":"https://doi.org/10.1097/coh.0b013e328322f95e","title":"Human monoclonal antibodies and engineered antibody domains as HIV-1 entry inhibitors","display_name":"Human monoclonal antibodies and engineered antibody domains as HIV-1 entry inhibitors","publication_year":2009,"publication_date":"2009-03-01","ids":{"openalex":"https://openalex.org/W1973123797","doi":"https://doi.org/10.1097/coh.0b013e328322f95e","mag":"1973123797","pmid":"https://pubmed.ncbi.nlm.nih.gov/19339949","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2762325"},"language":"en","primary_location":{"id":"doi:10.1097/coh.0b013e328322f95e","doi":"https://doi.org/10.1097/coh.0b013e328322f95e","is_oa":false,"landing_page_url":"https://doi.org/10.1097/coh.0b013e328322f95e","pdf_url":null,"source":{"id":"https://openalex.org/S106953758","display_name":"Current Opinion in HIV and AIDS","issn_l":"1746-630X","issn":["1746-630X","1746-6318"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","medline","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Opinion in HIV and AIDS","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2762325","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067025401","display_name":"Weizao Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210149717","display_name":"Center for Cancer Research","ror":"https://ror.org/05bjen692","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Weizao Chen","raw_affiliation_strings":["Protein Interactions Group, CCRNP, CCR, NCI-Frederick, NIH, Frederick, MD 21702-1201, USA. chenw@ncifcrf.gov","Protein Interactions Group, CCRNP, CCR, NCI-Frederick, NIH, Frederick, Maryland, USA","e-mail: [email\u00a0protected]","fax: +1 301 846 5598","to Weizao Chen, CCRNP, CCR, NCI-Frederick, NIH, Building 469, Room 144, Frederick, MD 21702-1201, USA Tel: +1 301 846 1770"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Protein Interactions Group, CCRNP, CCR, NCI-Frederick, NIH, Frederick, MD 21702-1201, USA. chenw@ncifcrf.gov","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"Protein Interactions Group, CCRNP, CCR, NCI-Frederick, NIH, Frederick, Maryland, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]},{"raw_affiliation_string":"e-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"fax: +1 301 846 5598","institution_ids":[]},{"raw_affiliation_string":"to Weizao Chen, CCRNP, CCR, NCI-Frederick, NIH, Building 469, Room 144, Frederick, MD 21702-1201, USA Tel: +1 301 846 1770","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089862290","display_name":"Dimiter Stanchev Dimitrov","orcid":"https://orcid.org/0000-0002-2258-1024","observed_orcids":["https://orcid.org/0000-0002-2258-1024"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210149717","display_name":"Center for Cancer Research","ror":"https://ror.org/05bjen692","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dimiter S Dimitrov","raw_affiliation_strings":["Protein Interactions Group, CCRNP, CCR, NCI-Frederick, NIH, Frederick, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Protein Interactions Group, CCRNP, CCR, NCI-Frederick, NIH, Frederick, Maryland, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5067025401"],"corresponding_institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884","https://openalex.org/I4210149717"],"apc_list":null,"apc_paid":null,"fwci":0.5384,"has_fulltext":false,"cited_by_count":37,"citation_normalized_percentile":{"value":0.42937853,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"4","issue":"2","first_page":"112","last_page":"117"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.009800000116229057,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-1-entry-inhibitors","display_name":"HIV-1 entry inhibitors","score":0.9259999990463257},{"id":"https://openalex.org/keywords/human-monoclonal-antibodies","display_name":"human monoclonal antibodies","score":0.9470000267028809},{"id":"https://openalex.org/keywords/domain-antibodies","display_name":"domain antibodies","score":0.8849999904632568},{"id":"https://openalex.org/keywords/hiv-1-envelope-glycoprotein","display_name":"HIV-1 envelope glycoprotein","score":0.7990000247955322},{"id":"https://openalex.org/keywords/gp120","display_name":"gp120","score":0.972000002861023},{"id":"https://openalex.org/keywords/neutralizing-antibodies","display_name":"neutralizing antibodies","score":0.781000018119812},{"id":"https://openalex.org/keywords/m-9","display_name":"M.9","score":0.7369999885559082},{"id":"https://openalex.org/keywords/conserved-epitopes","display_name":"conserved epitopes","score":0.6150000095367432},{"id":"https://openalex.org/keywords/antiretroviral-drug-resistance","display_name":"antiretroviral resistance","score":0.7089999914169312}],"concepts":[{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.8651262521743774},{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.7792845964431763},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.7737575769424438},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.6306555867195129},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4790838360786438},{"id":"https://openalex.org/C108625454","wikidata":"https://www.wikidata.org/wiki/Q187126","display_name":"Glycoprotein","level":2,"score":0.44821539521217346},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4479863941669464},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.42176857590675354},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3596344590187073},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.14987754821777344},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07112890481948853},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009500","descriptor_name":"Neutralization Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015699","descriptor_name":"HIV Envelope Protein gp120","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D023581","descriptor_name":"HIV Fusion Inhibitors","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D023581","descriptor_name":"HIV Fusion Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1097/coh.0b013e328322f95e","doi":"https://doi.org/10.1097/coh.0b013e328322f95e","is_oa":false,"landing_page_url":"https://doi.org/10.1097/coh.0b013e328322f95e","pdf_url":null,"source":{"id":"https://openalex.org/S106953758","display_name":"Current Opinion in HIV and AIDS","issn_l":"1746-630X","issn":["1746-630X","1746-6318"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","medline","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Opinion in HIV and AIDS","raw_type":"journal-article"},{"id":"pmid:19339949","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19339949","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in HIV and AIDS","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2762325","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2762325","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Curr Opin HIV AIDS","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:2762325","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2762325","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Curr Opin HIV AIDS","raw_type":"Text"},"sustainable_development_goals":[{"score":0.8999999761581421,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.699999988079071,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G5511856655","display_name":"Human Monoclonal Antibodies and Antibody-Guided Nanoparticles","funder_award_id":"Z01BC010701","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":45,"referenced_works":["https://openalex.org/W111944915","https://openalex.org/W1628484047","https://openalex.org/W1794879226","https://openalex.org/W1842798465","https://openalex.org/W1973489387","https://openalex.org/W1976595872","https://openalex.org/W1982622656","https://openalex.org/W1984395968","https://openalex.org/W1996538960","https://openalex.org/W1997677784","https://openalex.org/W2000564337","https://openalex.org/W2030129290","https://openalex.org/W2033611972","https://openalex.org/W2033694602","https://openalex.org/W2035316919","https://openalex.org/W2045882462","https://openalex.org/W2055031783","https://openalex.org/W2058597041","https://openalex.org/W2065329551","https://openalex.org/W2071200370","https://openalex.org/W2077153526","https://openalex.org/W2090763940","https://openalex.org/W2094180923","https://openalex.org/W2097478805","https://openalex.org/W2098781795","https://openalex.org/W2099308199","https://openalex.org/W2102548388","https://openalex.org/W2110287237","https://openalex.org/W2112011162","https://openalex.org/W2116759309","https://openalex.org/W2116917652","https://openalex.org/W2119423559","https://openalex.org/W2123619797","https://openalex.org/W2125231927","https://openalex.org/W2125962158","https://openalex.org/W2126977955","https://openalex.org/W2128873769","https://openalex.org/W2132239186","https://openalex.org/W2141054917","https://openalex.org/W2144023036","https://openalex.org/W2146029618","https://openalex.org/W2151835606","https://openalex.org/W2155058406","https://openalex.org/W2157210912","https://openalex.org/W2177434887"],"related_works":["https://openalex.org/W1964822568","https://openalex.org/W1996538960","https://openalex.org/W2102670802","https://openalex.org/W2098535215","https://openalex.org/W2120399100","https://openalex.org/W2083791326","https://openalex.org/W1876071032","https://openalex.org/W2001419705","https://openalex.org/W2087592979","https://openalex.org/W7101014744"],"abstract_inverted_index":{"PURPOSE":[0],"OF":[1],"REVIEW:":[2],"To":[3],"summarize":[4],"the":[5,17,58,94,100,122,146,156,164,173,253,269],"in-vivo":[6],"efficacy":[7,162],"of":[8,60,65,80,96,145,163,192,233,242,248],"neutralizing":[9,36,132,149,198],"human":[10,23,71,109,150,199,224],"monoclonal":[11,151,200],"antibodies":[12,54,97,201,263],"against":[13,38,134,205],"HIV-1,":[14],"to":[15,56,82,172,188,213],"discuss":[16],"recent":[18],"finding":[19],"that":[20,48,107,241,257],"an":[21,185,243],"engineered":[22],"antibody":[24,28,225],"VH":[25],"domain,":[26],"domain":[27],"(dAb),":[29],"exhibits":[30,129],"exceptionally":[31,130],"potent":[32,66,131,193,231],"and":[33,55,90,128,155,178,264,279],"broadly":[34,147,196],"cross-reactive":[35,148,197],"activity":[37,133],"HIV-1":[39,67,75,123,135,206,254,276],"primary":[40,136],"isolates":[41],"by":[42,52,99,170,261],"targeting":[43,247],"a":[44,62,78,108,117],"hidden":[45],"conserved":[46,89,250],"epitope":[47],"is":[49,167],"not":[50,259],"accessible":[51,260],"larger":[53],"suggest":[57],"possibility":[59],"developing":[61],"novel":[63,190],"class":[64],"inhibitors":[68],"based":[69],"on":[70,121,140,252],"dAbs.":[72],"RECENT":[73],"FINDINGS:":[74],"has":[76,216],"evolved":[77],"number":[79],"strategies":[81],"evade":[83],"humoral":[84],"immunity,":[85],"including":[86],"protecting":[87],"highly":[88,118,203,249],"important":[91],"structures":[92,251],"from":[93],"access":[95],"generated":[98],"immune":[101],"system.":[102],"We":[103],"have":[104],"recently":[105],"demonstrated":[106],"dAb":[110],"(size":[111],"approximately":[112],"15":[113],"kDa),":[114],"m36,":[115],"targets":[116],"protected":[119],"structure":[120],"envelope":[124,255],"glycoprotein":[125,256],"(Env),":[126],"gp120,":[127],"isolates,":[137],"with":[138],"potency":[139],"average":[141],"higher":[142],"than":[143,240],"those":[144],"antibody,":[152],"scFv":[153],"m9,":[154],"inhibitory":[157],"peptide,":[158],"C34.":[159],"SUMMARY:":[160],"The":[161],"anti-HIV-1":[165],"therapy":[166],"significantly":[168],"compromised":[169],"resistance":[171],"currently":[174],"used":[175],"US":[176],"Food":[177],"Drug":[179],"Administration-approved":[180],"antiretroviral":[181],"drugs,":[182],"which":[183,245,275],"suggests":[184],"urgent":[186],"need":[187],"develop":[189],"classes":[191],"inhibitors.":[194],"Several":[195],"are":[202,258],"effective":[204],"infection":[207],"in":[208,219,274],"vitro,":[209],"but":[210],"their":[211,234],"administration":[212],"HIV-1-infected":[214],"humans":[215],"only":[217],"resulted":[218],"modest":[220],"antiviral":[221],"effects.":[222],"Engineered":[223],"fragments,":[226],"dAbs,":[227],"could":[228],"be":[229],"more":[230],"because":[232],"small":[235],"size":[236],"(about":[237],"10-fold":[238],"smaller":[239],"IgG),":[244],"allows":[246],"full-size":[262],"relatively":[265],"efficient":[266],"penetration":[267],"into":[268],"densely":[270],"packed":[271],"lymphoid":[272],"environment":[273],"mostly":[277],"replicates":[278],"spreads.":[280]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":6}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}